Fieldpoint Private Securities, LLC Benitec Biopharma Inc. Transaction History

Fieldpoint Private Securities, LLC

  • $344 Million
  • Q2 2022

A detailed history of Fieldpoint Private Securities, LLC transactions in Benitec Biopharma Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 3 shares of BNTC stock, worth $26. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 9 66.67%
Holding current value
$26
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$0.74 - $2.29 $4 - $13
-6 Reduced 66.67%
3 $0
Q3 2021

Nov 12, 2021
BUY
$3.49 - $4.26 $31 - $38
9 New
9 $0

Others Institutions Holding BNTC

# of Institutions
3
Shares Held
1.42M
Call Options Held
0
Put Options Held
0
View Full List

About Benitec Biopharma Inc.

BNTC Quotes by TradingView
  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $224M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email